Roger Stupp Selected Research

Antineoplastic Agents (Antineoplastics)

10/2016	Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trial.
8/2009	Epigenetic deregulation of DNA repair and its potential for therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roger Stupp Research Topics

Disease

105	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 03/2002
94	Neoplasms (Cancer) 04/2024 - 01/2003
56	Glioma (Gliomas) 01/2024 - 10/2003
15	Brain Neoplasms (Brain Tumor) 04/2024 - 06/2004
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 05/2003
9	Astrocytoma (Pilocytic Astrocytoma) 11/2016 - 03/2002
7	Neoplasm Metastasis (Metastasis) 06/2023 - 02/2004
7	Seizures (Absence Seizure) 01/2023 - 02/2009
6	Thrombocytopenia (Thrombopenia) 01/2022 - 03/2002
6	Neutropenia 01/2022 - 03/2002
6	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2006
6	Epilepsy (Aura) 10/2021 - 12/2010
5	Fatigue 01/2023 - 11/2016
5	Melanoma (Melanoma, Malignant) 01/2020 - 02/2006
5	Oligodendroglioma 11/2016 - 02/2006
4	Lymphopenia (Lymphocytopenia) 01/2022 - 06/2006
4	Disease Progression 09/2014 - 02/2004
3	Nausea 01/2022 - 06/2006
3	Multiple Myeloma 01/2018 - 01/2015
3	Body Weight (Weight, Body) 01/2018 - 01/2015
3	Pain (Aches) 01/2018 - 01/2003
3	Infections 11/2016 - 09/2012
3	Hypoxia (Hypoxemia) 10/2016 - 01/2009
3	Necrosis 01/2013 - 10/2003
3	Colorectal Neoplasms (Colorectal Cancer) 06/2008 - 04/2002
3	Carcinoma (Carcinomatosis) 08/2007 - 08/2003
2	Vomiting 01/2022 - 01/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2009
2	Carcinogenesis 01/2020 - 01/2003
2	Malignant Mesothelioma 01/2018 - 09/2008
2	Lymphoma (Lymphomas) 01/2018 - 12/2010
2	Pneumonia (Pneumonitis) 01/2018 - 06/2006
2	Headache (Headaches) 10/2017 - 06/2006
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2010 - 06/2004

Drug/Important Bio-Agent (IBA)

67	Temozolomide (Temodar)FDA LinkGeneric 01/2024 - 03/2002
18	Biomarkers (Surrogate Marker)IBA 11/2023 - 12/2003
14	MethyltransferasesIBA 01/2019 - 03/2004
14	CilengitideIBA 05/2018 - 09/2007
13	IntegrinsIBA 07/2019 - 09/2007
13	Alkylating AgentsIBA 10/2012 - 03/2002
11	Anticonvulsants (Antiepileptic Drugs)IBA 01/2023 - 02/2009
10	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 08/2006
9	Bevacizumab (Avastin)FDA Link 11/2017 - 09/2007
7	Lomustine (CCNU)FDA Link 11/2022 - 09/2007
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2006
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 10/2003
5	Angiogenesis InhibitorsIBA 11/2023 - 12/2003
5	O-(6)-methylguanineIBA 01/2019 - 09/2008
5	EnzymesIBA 01/2019 - 01/2007
5	Cisplatin (Platino)FDA LinkGeneric 11/2018 - 05/2003
5	O(6)-Methylguanine-DNA MethyltransferaseIBA 10/2012 - 08/2006
4	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2024 - 09/2012
4	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2018
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016 - 06/2006
4	Imatinib Mesylate (Gleevec)FDA Link 03/2012 - 02/2006
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 01/2020
3	Albumin-Bound Paclitaxel FDA Link 01/2023 - 01/2020
3	Antimitotic AgentsIBA 01/2022 - 12/2015
3	Levetiracetam (Keppra)FDA LinkGeneric 01/2022 - 04/2014
3	ChromatinIBA 01/2021 - 01/2011
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 09/2007
3	Vincristine (Oncovin)FDA LinkGeneric 01/2020 - 09/2007
3	Procarbazine (Matulane)FDA Link 01/2020 - 09/2007
3	Vinorelbine (Navelbine)FDA LinkGeneric 01/2018 - 01/2015
3	Filgrastim (Neupogen)FDA Link 01/2018 - 01/2015
3	Rituximab (Mabthera)FDA Link 01/2014 - 06/2004
3	ErbB Receptors (EGF Receptor)IBA 06/2008 - 02/2006
2	Carboplatin (JM8)FDA LinkGeneric 02/2024 - 01/2024
2	CateninsIBA 01/2020 - 12/2011
2	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2018
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2019 - 11/2017
2	Gemcitabine FDA Link 11/2018 - 01/2009
2	IpilimumabIBA 01/2018 - 12/2012
2	AntigensIBA 01/2018 - 12/2012
2	Antineoplastic Agents (Antineoplastics)IBA 10/2016 - 08/2009
2	temsirolimus FDA Link 10/2016 - 09/2007
2	Dexamethasone (Maxidex)FDA LinkGeneric 03/2016 - 01/2016
2	SteroidsIBA 03/2016 - 01/2016
2	Valproic Acid (Depakote)FDA LinkGeneric 03/2016 - 12/2008
2	Prostaglandins BIBA 04/2014 - 02/2009
2	Pregabalin (Lyrica)FDA Link 04/2014 - 02/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013 - 01/2013
2	EMD 521873IBA 01/2013 - 01/2013
2	Interleukin-2 (IL2)IBA 01/2013 - 01/2013
2	A-Form DNA (A-DNA)IBA 01/2013 - 01/2007
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 03/2012 - 02/2006
2	Gefitinib (Iressa)FDA Link 02/2012 - 02/2006
2	GuanineIBA 01/2011 - 09/2007
2	Peptides (Polypeptides)IBA 01/2011 - 08/2008

Therapy/Procedure

64	Radiotherapy 11/2023 - 01/2003
59	Therapeutics 04/2024 - 03/2002
51	Drug Therapy (Chemotherapy) 02/2023 - 01/2003
23	Chemoradiotherapy 01/2022 - 03/2002
10	Immunotherapy 11/2023 - 01/2016
3	Adjuvant Chemotherapy 02/2023 - 03/2002
3	Aftercare (After-Treatment) 11/2022 - 01/2020
3	Neoadjuvant Therapy 09/2015 - 05/2003
3	Precision Medicine 01/2012 - 01/2010
2	Adjuvant Radiotherapy 01/2019 - 03/2005
2	Oral Administration 11/2016 - 04/2014